SPOTLIGHT -
Expert perspectives on the prevention and treatment of tumor lysis syndrome (TLS) in patients on therapy for cancer.
EP. 1: Coming Soon: Prevention and Treatment of Tumor Lysis Syndrome
EP. 2: Overview on Tumor Lysis Syndrome: Incidence and Risk Factors
EP. 3: Identification of Tumor Lysis Syndrome: Signs and Symptoms
EP. 4: Role of a Multidisciplinary Healthcare Team to Manage Tumor Lysis Syndrome
EP. 5: Prophylactic Measures to Prevent Tumor Lysis Syndrome
EP. 6: Guideline-Directed Treatment Options for Tumor Lysis Syndrome
EP. 7: Tumor Lysis Syndrome: Clinical Implications of Prophylaxis and Treatment
PD-1 Inhibitor Combinations, Alternative Therapeutic Approaches Are Moving the Needle in NSCLC
Better Understanding of Biomarkers Can Inform Immunotherapy Treatment in SCLC
Second-Line Treatment of R/R LBCL With Lisocabtagene Maraleucel (Liso-cel)
ZUMA-7: Axicabtagene Ciloleucel as a Second-Line Therapy for LBCL